The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
Am J Clin Oncol
; 31(5): 446-53, 2008 Oct.
Article
em En
| MEDLINE
| ID: mdl-18838880
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pancreatectomia
/
Neoplasias Pancreáticas
/
Adenocarcinoma
/
Antígeno CA-19-9
/
Fluoruracila
/
Recidiva Local de Neoplasia
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2008
Tipo de documento:
Article